die('
Site is under construction
Dear site users
Site is under construction.
The site will be ready in less than 24 hours.
We are sorry for the inconvenience.
www.yektaweb.com
');
Reports of Biochemistry and Molecular Biology
rbmb.net
Basic Sciences
http://rbmb.net
1
admin
2322-3480
2322-3480
10.61882/rbmb
en
jalali
1397
10
1
gregorian
2019
1
1
7
2
online
1
fulltext
en
Investigation of CEBPA and CEBPA-AS Genes Expression in Acute Myeloid Leukemia
زیست شناسی ملکولی
Molecular Biology
مقالات اصلی
Original Article
<div style="text-align: justify;"><strong><em>Background:</em></strong> The pathogenicity of acute myeloid leukemia (AML) is highly influenced by genetic alterations, such as chromosomal abnormalities. Additionally, aberrations in the mechanisms involved in gene expression have been identified to have a role in the development of AML. Contradictory evidence has been reported concerning the expression of the <em>CEBPA</em> gene in AML patients. Additionally, investigation into the expression of the <em>CEBPA-AS</em> gene has yet to be explored in AML patients. The aim of the present study was to investigate the relationship between the expression of the <em>CEBPA</em> and <em>CEBPA-AS</em> genes and AML in Iranian patients.<br>
<strong><em>Methods:</em></strong> Using quantitative real-time PCR, the expression of the <em>CEBPA</em> and <em>CEBPA-AS</em> genes was examined in the peripheral blood samples of 58 patients with de novo adult AML, and in 20 healthy controls. <br>
<strong><em>Results:</em></strong> Overall, <em>CEBPA</em> expression analysis showed a significant up-regulation in AML patients compared with healthy controls. Interestingly, a significant up-regulation of <em>CEBPA</em> was detected in the male AML patients. Significant <em>CEBPA</em> over-expression was observed in M0 (<em>p-value</em>=0.0001), M3 (<em>p-value</em>= 0.012) and M4 (<em>p-value</em>= 0.000) FAB subtypes. Our data has also demonstrated that <em>CEBPA</em> expression is up-regulated in favorable (<em>p</em>-v<em>alue</em>= 0.006) and adverse (<em>p-value</em>= 0.042) cytogenetic risk groups. In addition, the expression of <em>CEBPA</em> was significantly increased in AML patients with an abnormal karyotype. Ectopic expression of <em>CEBPA-AS</em> was detected in seven of the AML patients.<br>
<strong><em>Conclusions:</em></strong> Our study provides evidence for the up-regulation of <em>CEBPA</em> and the ectopic expression of <em>CEBPA-AS</em> in AML patients, suggesting that these two genes may play an important role in the pathogenesis of AML. The role of <em>CEBPA and CEBPA-AS </em>in AML patients should be further explored. This will offer potential opportunities for the development of novel treatment strategies.<br>
</div>
Acute Myeloid Leukemia, CEBPA, CEBPA-AS, de novo, Expression.
136
141
http://rbmb.net/browse.php?a_code=A-10-134-1&slc_lang=en&sid=1
Milad
Gholami
mtu.q220@gmail.com
100319475328460017024
100319475328460017024
No
Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sahar
Bayat
Bayatsahar40@gmail.com
100319475328460017025
100319475328460017025
No
Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Saba
Manoochehrabadi
saba.manoochehri68@gmail.com
100319475328460017026
100319475328460017026
No
Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran & Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Hossein
Pashaiefar
am_irr@yahoo.com
100319475328460017027
100319475328460017027
No
Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mir Davood
Omrani
remir_2002@yahoo.com
100319475328460017028
100319475328460017028
No
Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hasan
Jalaeikhoo
jalaeikhoo@gmail.com
100319475328460017029
100319475328460017029
No
AJA Cancer Research Center (ACRC), AJA University of Medical Sciences, Tehran, Iran.
Vahid Reza
Yassaee
v.yassaee-grc@sbmu.ac.ir
100319475328460017030
100319475328460017030
No
Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad Reza
Ebrahimpour
Mohamadreza.ebrahimpour@yahoo.com
100319475328460017031
100319475328460017031
No
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Farkhondeh
Behjati
fbehjati@gmail.com
100319475328460017032
100319475328460017032
No
Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Reza
Mirfakhraie
reza_mirfakhraie@yahoo.com
100319475328460017033
100319475328460017033
Yes
Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran & Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.